Shares of Plexus Corp. (NASDAQ:PLXS – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the four ratings firms that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $124.00.
Several analysts recently issued reports on the stock. Needham & Company LLC upped their price objective on shares of Plexus from $114.00 to $144.00 and gave the company a “buy” rating in a research note on Friday, July 26th. Benchmark boosted their target price on Plexus from $120.00 to $145.00 and gave the stock a “buy” rating in a report on Monday, July 29th.
View Our Latest Stock Analysis on PLXS
Insiders Place Their Bets
Institutional Inflows and Outflows
Several hedge funds have recently bought and sold shares of PLXS. Creative Planning raised its stake in shares of Plexus by 47.1% in the 2nd quarter. Creative Planning now owns 9,371 shares of the technology company’s stock valued at $967,000 after acquiring an additional 2,999 shares during the period. Disciplined Growth Investors Inc. MN raised its position in Plexus by 0.3% in the second quarter. Disciplined Growth Investors Inc. MN now owns 2,109,047 shares of the technology company’s stock valued at $217,611,000 after purchasing an additional 7,245 shares during the period. Algert Global LLC purchased a new stake in Plexus in the second quarter valued at approximately $287,000. Scientech Research LLC acquired a new position in Plexus during the second quarter worth $347,000. Finally, The Manufacturers Life Insurance Company boosted its position in shares of Plexus by 2.7% during the second quarter. The Manufacturers Life Insurance Company now owns 14,864 shares of the technology company’s stock worth $1,534,000 after buying an additional 384 shares during the period. Hedge funds and other institutional investors own 94.45% of the company’s stock.
Plexus Price Performance
Shares of Plexus stock opened at $123.00 on Thursday. The stock has a market capitalization of $3.35 billion, a P/E ratio of 33.98 and a beta of 0.89. The business has a 50 day simple moving average of $118.00 and a two-hundred day simple moving average of $106.30. Plexus has a 12 month low of $87.21 and a 12 month high of $132.46. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 0.64.
Plexus (NASDAQ:PLXS – Get Free Report) last posted its quarterly earnings data on Wednesday, July 24th. The technology company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.28 by $0.17. Plexus had a return on equity of 9.64% and a net margin of 2.82%. The firm had revenue of $960.70 million during the quarter, compared to the consensus estimate of $981.32 million. During the same period in the prior year, the company earned $1.32 EPS. The firm’s revenue was down 6.0% compared to the same quarter last year. As a group, analysts predict that Plexus will post 3.74 EPS for the current fiscal year.
About Plexus
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Further Reading
- Five stocks we like better than Plexus
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Why Dick’s Could Be a Slam Dunk for Your Investment Portfolio
- How to Invest in the Best Canadian Stocks
- Introduction to Fibonacci Retracement Levels
- What is a Bond Market Holiday? How to Invest and Trade
- Top 3 Stocks to Outperform the S&P 500 in a Downturn
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.